In vitro chemosensitivity testing of leukemic cells

Development of a semiautomated colorimetry assay

P. A. Bernabei, V. Santini, L. Silvestro, O. Dal Pozzo, R. Bezzini, I. Viano, V. Gattei, R. Saccardi, P. Rossi Ferrini

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A rapid chemosensitivity assay was developed, employing the human continuous leukemic cell lines HL60, K 562, FLG 29.1. This automated colorimetric assay is based on the characteristic of viable, metabolically active cells to cleave p-iodonitrotetrazolium violet (INT) into a red formazan derivative, whose optical density is readable at 492 nm by an automated microtiter-plate reader photometer. A linear relationship was found between the viable cell number and the optical density of INT cleaved by the cellular samples. Dead cells did not reduce INT and did not interfere with the formazan derivative generation and the photometric reading. Leukemic cell lines were also tested for INT formazan derivative generation after exposure to antileukemic drugs at various concentrations, representative of plasma levels obtainable in vivo. A dose-dependent inhibition was detected, with different sensitivity patterns, related both to the drugs and to the different cell lines. A significant correlation between the viable cell number and the amount of tetrazolium salt cleaved was also demonstrated after drug exposure. INT assay allows the processing of a great number of samples and gives the opportunity to screen several drugs, saving time and yielding fully reliable results.

Original languageEnglish
Pages (from-to)243-253
Number of pages11
JournalHematological Oncology
Volume7
Issue number3
Publication statusPublished - 1989

Fingerprint

Colorimetry
Formazans
Cell Line
Pharmaceutical Preparations
Cell Count
Tetrazolium Salts
Reading
iodonitrotetrazolium
In Vitro Techniques

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Bernabei, P. A., Santini, V., Silvestro, L., Dal Pozzo, O., Bezzini, R., Viano, I., ... Rossi Ferrini, P. (1989). In vitro chemosensitivity testing of leukemic cells: Development of a semiautomated colorimetry assay. Hematological Oncology, 7(3), 243-253.

In vitro chemosensitivity testing of leukemic cells : Development of a semiautomated colorimetry assay. / Bernabei, P. A.; Santini, V.; Silvestro, L.; Dal Pozzo, O.; Bezzini, R.; Viano, I.; Gattei, V.; Saccardi, R.; Rossi Ferrini, P.

In: Hematological Oncology, Vol. 7, No. 3, 1989, p. 243-253.

Research output: Contribution to journalArticle

Bernabei, PA, Santini, V, Silvestro, L, Dal Pozzo, O, Bezzini, R, Viano, I, Gattei, V, Saccardi, R & Rossi Ferrini, P 1989, 'In vitro chemosensitivity testing of leukemic cells: Development of a semiautomated colorimetry assay', Hematological Oncology, vol. 7, no. 3, pp. 243-253.
Bernabei PA, Santini V, Silvestro L, Dal Pozzo O, Bezzini R, Viano I et al. In vitro chemosensitivity testing of leukemic cells: Development of a semiautomated colorimetry assay. Hematological Oncology. 1989;7(3):243-253.
Bernabei, P. A. ; Santini, V. ; Silvestro, L. ; Dal Pozzo, O. ; Bezzini, R. ; Viano, I. ; Gattei, V. ; Saccardi, R. ; Rossi Ferrini, P. / In vitro chemosensitivity testing of leukemic cells : Development of a semiautomated colorimetry assay. In: Hematological Oncology. 1989 ; Vol. 7, No. 3. pp. 243-253.
@article{6a50cdf4143740c3881ba26f34eff842,
title = "In vitro chemosensitivity testing of leukemic cells: Development of a semiautomated colorimetry assay",
abstract = "A rapid chemosensitivity assay was developed, employing the human continuous leukemic cell lines HL60, K 562, FLG 29.1. This automated colorimetric assay is based on the characteristic of viable, metabolically active cells to cleave p-iodonitrotetrazolium violet (INT) into a red formazan derivative, whose optical density is readable at 492 nm by an automated microtiter-plate reader photometer. A linear relationship was found between the viable cell number and the optical density of INT cleaved by the cellular samples. Dead cells did not reduce INT and did not interfere with the formazan derivative generation and the photometric reading. Leukemic cell lines were also tested for INT formazan derivative generation after exposure to antileukemic drugs at various concentrations, representative of plasma levels obtainable in vivo. A dose-dependent inhibition was detected, with different sensitivity patterns, related both to the drugs and to the different cell lines. A significant correlation between the viable cell number and the amount of tetrazolium salt cleaved was also demonstrated after drug exposure. INT assay allows the processing of a great number of samples and gives the opportunity to screen several drugs, saving time and yielding fully reliable results.",
author = "Bernabei, {P. A.} and V. Santini and L. Silvestro and {Dal Pozzo}, O. and R. Bezzini and I. Viano and V. Gattei and R. Saccardi and {Rossi Ferrini}, P.",
year = "1989",
language = "English",
volume = "7",
pages = "243--253",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "wiley",
number = "3",

}

TY - JOUR

T1 - In vitro chemosensitivity testing of leukemic cells

T2 - Development of a semiautomated colorimetry assay

AU - Bernabei, P. A.

AU - Santini, V.

AU - Silvestro, L.

AU - Dal Pozzo, O.

AU - Bezzini, R.

AU - Viano, I.

AU - Gattei, V.

AU - Saccardi, R.

AU - Rossi Ferrini, P.

PY - 1989

Y1 - 1989

N2 - A rapid chemosensitivity assay was developed, employing the human continuous leukemic cell lines HL60, K 562, FLG 29.1. This automated colorimetric assay is based on the characteristic of viable, metabolically active cells to cleave p-iodonitrotetrazolium violet (INT) into a red formazan derivative, whose optical density is readable at 492 nm by an automated microtiter-plate reader photometer. A linear relationship was found between the viable cell number and the optical density of INT cleaved by the cellular samples. Dead cells did not reduce INT and did not interfere with the formazan derivative generation and the photometric reading. Leukemic cell lines were also tested for INT formazan derivative generation after exposure to antileukemic drugs at various concentrations, representative of plasma levels obtainable in vivo. A dose-dependent inhibition was detected, with different sensitivity patterns, related both to the drugs and to the different cell lines. A significant correlation between the viable cell number and the amount of tetrazolium salt cleaved was also demonstrated after drug exposure. INT assay allows the processing of a great number of samples and gives the opportunity to screen several drugs, saving time and yielding fully reliable results.

AB - A rapid chemosensitivity assay was developed, employing the human continuous leukemic cell lines HL60, K 562, FLG 29.1. This automated colorimetric assay is based on the characteristic of viable, metabolically active cells to cleave p-iodonitrotetrazolium violet (INT) into a red formazan derivative, whose optical density is readable at 492 nm by an automated microtiter-plate reader photometer. A linear relationship was found between the viable cell number and the optical density of INT cleaved by the cellular samples. Dead cells did not reduce INT and did not interfere with the formazan derivative generation and the photometric reading. Leukemic cell lines were also tested for INT formazan derivative generation after exposure to antileukemic drugs at various concentrations, representative of plasma levels obtainable in vivo. A dose-dependent inhibition was detected, with different sensitivity patterns, related both to the drugs and to the different cell lines. A significant correlation between the viable cell number and the amount of tetrazolium salt cleaved was also demonstrated after drug exposure. INT assay allows the processing of a great number of samples and gives the opportunity to screen several drugs, saving time and yielding fully reliable results.

UR - http://www.scopus.com/inward/record.url?scp=0024498877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024498877&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 243

EP - 253

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

IS - 3

ER -